Takeda Pharmaceuticals, UAE

Humaid Al-Shamsi – Director, Burjeel Oncology GCC

As the UAE’s only gastrointestinal oncologist, Professor Humaid Al-Shamsi is well-placed to comment on the evolution of cancer care in the country, noting massive leaps forward in terms of technology,…

Mourad Ishak – General Manager MEA Region, Farmak

Mourad Ishak began heading up Farmak’s MEA region as general manager in 2021, after almost two decades in the industry. He explains the Ukranian complex generics maker’s decision to set…

Clinical Research in the UAE: Quickfire Progress & The Road Left to Travel

With cutting-edge hospital infrastructure being put in place, government authorities rolling out evermore supportive regulatory upgrades, big pharma championing ‘clinical trial diversity’ with greater non-Caucasian representation in trial cohorts, and…

Ashraf Mallak – Managing Director GCC, MSD

MSD GCC’s Ashraf Mallak looks back on a “transformational” two years since his last PharmaBoardroom interview back in 2021, with the set up of a new regional office, a raft…

Myriam Hakim – Regional Nephrology Franchise Head EMEA, Kyowa Kirin

Erstwhile general manager for the GCC countries at Japanese-headquartered rare disease specialist Kyowa Kirin, earlier this year Myriam Hakim was appointed as the firm’s regional nephrology franchise head for the…

Noura Al Ghaithi – Undersecretary of the Department of Health Abu Dhabi

Speaking exclusively to PharmaBoardroom, H.E. Dr Noura Al Ghaithi, Undersecretary of the Department of Health Abu Dhabi outlines Abu Dhabi’s rapid progression towards becoming a global life science hub, how…

Ahmed Moustafa – General Manager Gulf Countries, Amgen

Ahmed Moustafa outlines the incredible development of the healthcare ecosystem in the UAE driven by a rapid ramping up of the country’s health infrastructure and a willingness on the part…

Ahmad Abu Dahab – Vice President Middle East, Turkey, and Northern Africa,…

Ahmad Abu Dahab became the first Middle East employee for Swedish-headquartered haematology, immunology and specialty care player SOBI back in 2012 and now serves as VP for the entire Middle…

Are Emerging Markets Back on Pharma’s Priority List?

As profit margins in established markets decreased, “pharmerging markets” became the new El Dorado for pharma and medtech companies in the 2010s. Many put in big investments only to discover…

Hassan Herrou – General Manager Middle East & Africa, CSL Behring

CSL Behring – which specalises in plasma-derived, and recombination therapeutic products – has undergone significant expansion in the Middle East and Africa (MEA) region in recent years under Hassan Herrou.…

Joe Henein – President & CEO, Newbridge Pharmaceuticals

NewBridge Pharmaceuticals’ Joe Henein describes how his MENA-focused specialty innovative biopharma distributor has developed over the last 13 years to become a market leader; looks at some of the key…

Khaled Harb – CEO, Dar Al Dawa

Less than two years into position as CEO of MENA-wide pharma and consumer health player Dar Al Dawa, Khaled Harb looks back on what has already been achieved and the…